Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointments

8 Feb 2007 07:00

Torex Retail PLC07 February 2007 7 February 2007 Torex retail plc (the "Company") Board Appointments Torex Retail plc, a leading global retail systems provider, today provides anupdate following the announcement of management actions issued on 31 January2007. The Company announces that Mr Keith Taylor has been appointed to the main Boardwith immediate effect as Acting Chief Executive Officer. Keith Taylor has justcompleted 7 months as Turnaround Director in the NHS. His IT sector experiencehas been at Morse Plc where he initially integrated the Diagonal acquisitionbefore going on to radically change their reseller business, which remains asuccessful service-led company. He was also Chief Operating Officer at Admiralplc where he was responsible for transforming the Group into a wholly integratedbusiness before its onward sale to CMG. Mr Iain Lynam has also been appointed to the main Board with immediate effectwith specific responsibility for managing any restructuring of the businesswhich may be appropriate. The Company also confirms that it remains in dialogue with its lenders whocontinue to be supportive of the restructuring process. The Board would like to take the opportunity to thank its employees, customersand suppliers for their support during this challenging time. The Company willmake a further announcement with a full financial update as soon as possible. - Ends - Enquiries: Keith TaylorActing CEO, Torex Retail plcTel: 0870 300 6061 Ginny Pulbrook / Seb Hoyle / Lucie HollowayCitigate Dewe RogersonTel: 020 7638 9571 Additional details are set out below: Keith Wilhall Taylor (age 58)Present directorships or partnerships: Crispins Partnership Ltd Directorships or partnerships in previous five years: Meta Management ServicesLimited, Aktrion Plus Limited, QE Recruitment Limited, QE Consultancy Limited,Aktrion Group Limited, QE International Limited, Aktrion Trustees Limited,Aktrion Manufacturing Support Services Limited, Panini (Europe) ltd Details of companies entering insolvency whilst a director or within 12 monthsof resignation: Panini (Europe) Limited - creditors voluntary liquidation No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies Robert Iain Lynam (age 54) Present directorships or partnerships: Combe Bank School Educational Trust,Imago Investments Limited, Citex UK Holdings Limited, Citex ProfessionalServices Limited, Citex Group Limited, Society of Turnaround Professionals, NSMT Ventures LimitedAaronite Partners Limited Directorships or partnerships in previous five years: Hudson EngineeringServices Limited, WRM Logistics Limited, Cbora Freehold Limited, ScriptorServices Limited, Sandiford Road Limited, GHE2 (2002) Limited, Unis GroupLimited, Citex Water & Facilities Limited, Bucknall Pck Limited, GH ElectricalGroup Limited, Bucknall Austin Project Management Services Limited, Frost BevanLimited, Tapley & Edworthy Limited,Marlin Construction Management Limited, BA Realisations Limited, Bucknall AustinFerris Watson Limited, Simok Limited, Unis Limited, FBA Limited, Citex Property& Facilities Limited, Frost Bevan Holdings Limited, Frost Bevan PartnershipLimited,Bucknall Sterling Programme Management Limited, Bucknall Limited, Citex ProjectDelivery Limited, VSI Limited, Sigma Building Solutions Limited, CitexInternational Holdings Limited, Citex Group Services Limited, Details of companies entering insolvency whilst a director or within 12 monthsof resignation: GH Electrical Group Limited - receivership, GHE2 (2002) Limited- receivership, Sandiford Road Limited - liquidation, HMG (South) Limited -receivership,HMG (Clearwater) Limited - receivership, HMG (London) Limited - receivership,HMG Holdings Limited - receivership, HMG (Thames) Limited - receivership,HMG (Midlands) Limited - receivership, Avidmoor Limited - receivership, HancockSouthern Limited -receivership, Hancock Group Limited - receivership, Citex UKHoldings Limited - liquidation, Citex Professional Services Limited -liquidation, Citex Group Limited - liquidation, No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies There is nothing further to disclose in relation to their appointment pursuantto Rule 17 of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.